Search Results - Hammerman, Peter S.

Refine Results
  1. 1
    Genomic Landscape of Human Papillomavirus–Associated Cancers

    Genomic Landscape of Human Papillomavirus–Associated Cancers by Rusan, Maria, Li, Yvonne Y., Hammerman, Peter S.

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    The Pim kinases control rapamycin-resistant T cell survival and activation

    The Pim kinases control rapamycin-resistant T cell survival and activation by Fox, Casey J., Hammerman, Peter S., Thompson, Craig B.

    Published 2005
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Therapeutic insights from genomic studies of head and neck squamous cell carcinomas

    Therapeutic insights from genomic studies of head and neck squamous cell carcinomas by Hammerman, Peter S., Hayes, D. Neil, Grandis, Jennifer R.

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Targeted therapy for squamous cell lung cancer

    Targeted therapy for squamous cell lung cancer by Liao, Rachel G., Watanabe, Hideo, Meyerson, Matthew, Hammerman, Peter S.

    Published 2012
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival

    Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival by Hammerman, Peter S., Fox, Casey J., Birnbaum, Morris J., Thompson, Craig B.

    Published 2005
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Non-small-cell lung cancers: a heterogeneous set of diseases

    Non-small-cell lung cancers: a heterogeneous set of diseases by Chen, Zhao, Fillmore, Christine M., Hammerman, Peter S., Kim, Carla F., Wong, Kwok-Kin

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Squamous Cell Lung Cancer: From Tumor Genomics to Cancer Therapeutics

    Squamous Cell Lung Cancer: From Tumor Genomics to Cancer Therapeutics by Gandara, David R., Hammerman, Peter S., Sos, Martin L., Lara, Primo N., Hirsch, Fred R.

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Challenges in EGFRvIII Detection in Head and Neck Squamous Cell Carcinoma

    Challenges in EGFRvIII Detection in Head and Neck Squamous Cell Carcinoma by Wheeler, Sarah E., Egloff, Ann Marie, Wang, Lin, James, C. David, Hammerman, Peter S., Grandis, Jennifer R.

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor

    The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor by Fox, Casey J., Hammerman, Peter S., Cinalli, Ryan M., Master, Stephen R., Chodosh, Lewis A., Thompson, Craig B.

    Published 2003
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Akt-Directed Glucose Metabolism Can Prevent Bax Conformation Change and Promote Growth Factor-Independent Survival

    Akt-Directed Glucose Metabolism Can Prevent Bax Conformation Change and Promote Growth Factor-Independent Survival by Rathmell, Jeffrey C., Fox, Casey J., Plas, David R., Hammerman, Peter S., Cinalli, Ryan M., Thompson, Craig B.

    Published 2003
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Genomic analysis of metastatic cutaneous squamous cell carcinoma

    Genomic analysis of metastatic cutaneous squamous cell carcinoma by Li, Yvonne Y., Hanna, Glenn J., Laga, Alvaro C., Haddad, Robert I., Lorch, Jochen H., Hammerman, Peter S.

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    The impact of the MYB-NFIB fusion proto-oncogene in vivo

    The impact of the MYB-NFIB fusion proto-oncogene in vivo by Mikse, Oliver R., Tchaicha, Jeremy H., Akbay, Esra A., Chen, Liang, Bronson, Roderick T., Hammerman, Peter S., Wong, Kwok-Kin

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    Multiple signaling pathways promote B lymphocyte stimulator–dependent B-cell growth and survival

    Multiple signaling pathways promote B lymphocyte stimulator–dependent B-cell growth and survival by Woodland, Robert T., Fox, Casey J., Schmidt, Madelyn R., Hammerman, Peter S., Opferman, Joseph T., Korsmeyer, Stanley J., Hilbert, David M., Thompson, Craig B.

    Published 2008
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    Ligand associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3 dependent cancer cells

    Ligand associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3 dependent cancer cells by Wang, Jun, Mikse, Oliver, Liao, Rachel G., Li, Yvonne, Tan, Li, Janne, Pasi A., Gray, Nathanael S., Wong, Kwok-kin, Hammerman, Peter S.

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    Cytokine stimulation of aerobic glycolysis in hematopoietic cells exceeds proliferative demand

    Cytokine stimulation of aerobic glycolysis in hematopoietic cells exceeds proliferative demand by Bauer, Daniel E., Harris, Marian H., Plas, David R., Lum, Julian J., Hammerman, Peter S., Rathmell, Jeffrey C., Riley, James L., Thompson, Craig B.

    Published 2004
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    Treatment-related Toxicities in a Phase II Trial of Dasatinib in Patients with Squamous Cell Carcinoma of the Lung: A Brief Report

    Treatment-related Toxicities in a Phase II Trial of Dasatinib in Patients with Squamous Cell Carcinoma of the Lung: A Brief Report by Brunner, Andrew M., Costa, Daniel B., Heist, Rebecca S., Garcia, Elizabeth, Lindeman, Neal I., Sholl, Lynette M., Oxnard, Geoffrey R., Johnson, Bruce E., Hammerman, Peter S.

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    Acquired resistance to dasatinib in lung cancer cell lines conferred by DDR2 gatekeeper mutation and NF1 loss

    Acquired resistance to dasatinib in lung cancer cell lines conferred by DDR2 gatekeeper mutation and NF1 loss by Beauchamp, Ellen M., Woods, Brittany A., Dulak, Austin M., Tan, Li, Xu, Chunxiao, Gray, Nathanael S., Bass, Adam J., Wong, Kwok-kin, Meyerson, Matthew, Hammerman, Peter S.

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  18. 18
    Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer

    Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer by Dutt, Amit, Ramos, Alex H., Hammerman, Peter S., Mermel, Craig, Cho, Jeonghee, Sharifnia, Tanaz, Chande, Ajit, Tanaka, Kumiko Elisa, Stransky, Nicolas, Greulich, Heidi, Gray, Nathanael S., Meyerson, Matthew

    Published 2011
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  19. 19
    Co-clinical quantitative tumor volume imaging in ALK-rearranged NSCLC treated with crizotinib

    Co-clinical quantitative tumor volume imaging in ALK-rearranged NSCLC treated with crizotinib by Nishino, Mizuki, Sacher, Adrian G., Gandhi, Leena, Chen, Zhao, Akbay, Esra, Fedorov, Andriy, Westin, Carl F., Hatabu, Hiroto, Johnson, Bruce E., Hammerman, Peter, Wong, Kwok-kin

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  20. 20
    Resistance to allosteric SHP2 inhibition in FGFR-driven cancers through rapid feedback activation of FGFR

    Resistance to allosteric SHP2 inhibition in FGFR-driven cancers through rapid feedback activation of FGFR by Lu, Hengyu, Liu, Chen, Huynh, Hung, Le, Thi Bich Uyen, LaMarche, Matthew J., Mohseni, Morvarid, Engelman, Jeffrey A., Hammerman, Peter S., Caponigro, Giordano, Hao, Huai-Xiang

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: